Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 17 Jun 2024

Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation

in Gastrointestinal and Hepatic Pharmacology

Hyekyung Yang
Dong Ho Suh
Eun Sung Jung
Yoonjin Lee
Kwang-Hyeon Liu
In-Gu Do
Choong Hwan Lee
Cheol-Young Park

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406493

1,590 views
2 citations

Original Research

Published on 14 Jun 2024

Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses

in Gastrointestinal and Hepatic Pharmacology

Yizhou Wang
Peipei Shang
Chang Xu
Wei Dong
Xiaofeng Zhang
Yong Xia
Chengjun Sui
Cheng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1416295

2,971 views
1 citation

Review

Published on 12 Jun 2024

Ginsenosides: an immunomodulator for the treatment of colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Jianan Qian
Yanyu Jiang
Hongyi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408993

2,685 views
2 citations

Original Research

Published on 05 Jun 2024

Quantitative evaluation of the time-course and efficacy of targeted agents for ulcerative colitis

in Gastrointestinal and Hepatic Pharmacology

Boran Yu
Siyao Jin
Jiaqi Han
Jiamin Xu
Shaolong Zhang
Yanming Li
Xiangyu Ma
Xiaoling Wang
Libo Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399963

1,833 views
1 citation

Original Research

Published on 03 Jun 2024

Untargeted metabonomics and TLR4/ NF-κB signaling pathway analysis reveals potential mechanism of action of Dendrobium huoshanense polysaccharide in nonalcoholic fatty liver disease

in Gastrointestinal and Hepatic Pharmacology

Guang-hui Deng
Chen-chen Zhao
Xiao Cai
Xiao-qian Zhang
Meng-zhen Ma
Jia-hui Lv
Wen-li Jiang
Dai-yin Peng
Yan-yan Wang
Li-hua Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374158

2,223 views
2 citations

Original Research

Published on 30 May 2024

Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system

in Gastrointestinal and Hepatic Pharmacology

Quanfeng Deng
Youlong Yang
Yuangui Liu
Mengting Zou
Guiyuan Huang
Shiqi Yang
Lingyu Li
Yueyang Qu
Yong Luo
Xiuli Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1335836

2,350 views
2 citations

Original Research

Published on 27 May 2024

Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice

in Gastrointestinal and Hepatic Pharmacology

Cenlu Xu
Haoran Tai
Yanan Chu
Ye Liu
Jiacheng He
Yiran Wang
Bingyin Su
Shurong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385330

1,689 views
2 citations

Original Research

Published on 27 May 2024

Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database

in Gastrointestinal and Hepatic Pharmacology

Khalidah A. Alenzi
Deemah Alsuhaibani
Bader Batarfi
Thamir M. Alshammari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364110

5,928 views
12 citations

Systematic Review

Published on 24 May 2024

A role for curcumin in preventing liver fibrosis in animals: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Bo-Hao Huang
Zi-Wei Guo
Bo-Han Lv
Xin Zhao
Yan-Bo Li
Wen-Liang Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396834

2,013 views
2 citations

Editorial

Published on 23 May 2024

Editorial: Exploring the roles of probiotics/postbiotics and gut microbiota on human health

in Gastrointestinal and Hepatic Pharmacology

Cheng Chung Yong
Chyn Boon Wong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430857

1,024 views

Original Research

Published on 23 May 2024

Bacillus coagulans and Clostridium butyricum synergistically alleviate depression in a chronic unpredictable mild stress mouse model through altering gut microbiota and prefrontal cortex gene expression

in Gastrointestinal and Hepatic Pharmacology

Jingyi Xu
Lei Zhou
Zhaowei Chen
Yuezhu Wang
Fang Xu
Qun Kuang
Yixuan Zhang
Huajun Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393874

2,465 views
3 citations

Original Research

Published on 21 May 2024

TRPC absence induces pro-inflammatory macrophage polarization to promote obesity and exacerbate colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Yanting Lin
Rui Gao
Dongquan Jing
Yiming Liu
Huijuan Da
Lutz Birnbaumer
Yong Yang
Xinghua Gao
Zhenhua Gao
Qiuhua Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392328

2,163 views

Original Research

Published on 17 May 2024

LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a

in Gastrointestinal and Hepatic Pharmacology

Devadoss J. Samuvel
John J. Lemasters
C. James Chou
Zhi Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1386238

2,548 views
2 citations

Original Research

Published on 14 May 2024

Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution

in Gastrointestinal and Hepatic Pharmacology

Xin Wang
Shuxia Cao
Yuan Huang
Liangchang Li
Dongyuan Xu
Lan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396023

2,493 views
2 citations

Original Research

Published on 09 May 2024

Clinical, endoscopic, pathological characteristics and management of cap polyposis: experience from a Tertiary Hospital in China

in Gastrointestinal and Hepatic Pharmacology

Yi Lu
Lingyu Huang
Xiaoying Lou
Chunyu Chen
Jiachen Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391367

1,110 views

Review

Published on 09 May 2024

Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms

in Gastrointestinal and Hepatic Pharmacology

Jiaxin Sun
Ying Wei
Jia Wang
Mingxing Hou
Liya Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377592

5,913 views
7 citations